your market intelligence analyst
Search Results
Edit Save
1,858 results
FindReps activity for 2Q 2020 hits record high amid COVID-19 lockdowns. NEWTOWN SQUARE, PA., US, July 13, 2020 / -- The Healthcare Sales & Marketing Network® (HSMN) reported today that FindReps® operations have reached a record h... Devices, Diagnostics, Biopharmaceuticals, Distribution Healthcare Sales & Marketing Network, HSMN, FindReps, Independent Sales Rep.
The McGuire Institute Study Compared Traditional Treatments for Periodontitis to BIOLASE REPAIR Perio Protocol. IRVINE, Calif., July 13, 2020 -- (Healthcare Sales & Marketing Network) -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, ...
TIANJIN, China, July 13, 2020 -- (Healthcare Sales & Marketing Network) -- SINOMED, a developer of innovative neuro- and cardiovascular technologies, announced the completion of the 1-year follow-up in the PIONEER-III, randomized global trial evaluating t...
STOCKHOLM, July 10, 2020 -- (Healthcare Sales & Marketing Network) -- Sedana Medical AB (publ) (SEDANA: FN Stockholm) today announced a positive top line result for the company's pivotal phase III study, IsoConDa. The study reached its primary endpoint; t... Biopharmaceuticals Sedana Medical, IsoConDa , isoflurane, inhaled sedation.
Simple new assay leverages more than 25,000 BD Veritor™ instruments already used across the U.S. to immediately increase access to COVID-19 testing in frontline health care settings. BD will begin shipping the new test this week and expects to ramp-up ma...
PESSAC, France, July 2, 2020 -- (Healthcare Sales & Marketing Network) -- inHEART, providing a cloud-based medical image analysis solution for cardiac interventions on patients with arrhythmias, has closed a round of EUR 3.7 million led by Elaia. These fu... Cardiology, Venture Capital inHEART , cardiac modeling.
FDA's "Enforcement Policy" and Orexo's strong financial position enable investments in an accelerated commercialization of its scientifically proven digital therapies. Preliminary estimated sales potential of USD 420-650 million for the DTx por... Biopharmaceuticals, Product Launch Orexo AB, Deprexis, Vorvida, digital therapies.

Financial Services

Business Issues

Companies - Public

Companies - Venture Funded

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Information Technologies

Job Titles

Legal and Regulatory

Political Entities


Strategic Scenarios



  • Actions
    • Bookmark and Share: Allows you to Bookmark the page for easy future retrieval and sharing with colleagues
    • Email: Opens a pop-up window where you can write a message to the recipient of the email
    • Copy URL: Copies the URL of the requested document for pasting in an email or other document
    • Previous Versions: Only shown if essentially the same document has been republished
  • Saved Searches and Alerts
    • Save your search for later viewing & updates by clicking the blue "Save" button to the right of the search box. 

Click here for more info on Search Results.